Tuesday, June 16, 2026

Latest

Tilray Q2 Earnings: What’s the Plan Here?

Another quarter, and another loss for Tilray Brands (TSX: TLRY) shareholders who are left wondering why they invested in the company in the first place.

Investors on Friday saw the equity sink as much as 15% after the release of the firms second quarter financial results, which were highlighted by single digit revenue growth that was offset by double-digit increases in net losses on a quarter over year basis.

The cannabis-turned distribution-turned alcohol brewer seems to be further away from profitability than ever, while attempting to woo investors by boasting about net revenue growth.

Lets dive in.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

One Response

  1. They have everything for success, they need a better planning team , I would get Palantir to make better judgments and then you’ll see profits, and when they legalize it we are going to be rolling in it 😉

Video Articles

Why Silver’s Next Move May Be Built on a Much Stronger Base | Mani Alkhafaji – First Majestic Silver

Guanajuato Silver Q1 Earnings: They Finally Post Positive Net Income

We’re in a New Era of Gold Price Discovery | Ryan King – Equinox Gold

Recommended

Antimony Resources Drills 5.45% Antimony Over 10.3 Metres At Bald Hill

PTX Metals Hits 92% Copper Recovery in Debut W2 Testwork

Related News

Tilray Makes Move Into US Cannabis Market Via Medmen Convertible Notes

It appears that the rumours surrounding Tilray’s (NASDAQ: TLRY) focus on the US cannabis market...

Tuesday, August 17, 2021, 04:30:09 PM

Tilray & Aphria: The Analyst Perspective

This morning it was announced that Aphria Inc (TSX: APHA) (NASDAQ: APHA) and Tilray Inc...

Wednesday, December 16, 2020, 02:04:02 PM

Tilray Reports FY2021 Results: US$513.1 Million In Revenue, US$336.0 Million Net Loss

Tilray Inc. (TSX: TLRY) released yesterday morning its full-year financial results for the 2021 fiscal...

Thursday, July 29, 2021, 07:01:00 AM

Tilray: Canaccord Cuts Price Target To $9.00

On January 10th, Tilray Inc (TSX: TLRY) reported their fiscal second-quarter financial results, the company...

Tuesday, January 11, 2022, 04:22:00 PM

Tilray Imports Medical Cannabis to USA to Assist Research on Breast Cancer Related Disorder

Tilray Inc (NASDAQ: TLRY) announced this morning that it has successfully imported medical cannabis from...

Thursday, October 24, 2019, 09:15:29 AM